End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,640 KRW | +15.73% |
|
+13.41% | -22.82% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Service
55.0
%
| 7,408 | 52.6 % | 7,857 | 55.0 % | +6.06% |
Immuno-cancer Drugs - Product
43.5
%
| 6,462 | 45.9 % | 6,212 | 43.5 % | -3.87% |
Usage Fee
1.5
%
| 212 | 1.5 % | 212 | 1.5 % | -0.13% |
Immuno-cancer Drugs - Merchandise
0.1
%
| 3 | 0.0 % | 16 | 0.1 % | +496.15% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 14,085 | 100.0 % | 14,296 | 100.0 % | +1.50% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Han-Su Park
CEO | Chief Executive Officer | 51 | 15-09-23 |
Ji-Soo Bae
FOU | Founder | 53 | 15-09-23 |
Young-Jin Seo
BRD | Director/Board Member | 44 | - |
Byung-Gyu Park
IRC | Investor Relations Contact | 44 | - |
Se-Hyun Jung
AUD | Comptroller/Controller/Auditor | 50 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Byeong-Geon Lee
BRD | Director/Board Member | 67 | - |
Ji-Soo Bae
FOU | Founder | 53 | 15-09-23 |
Han-Su Park
CEO | Chief Executive Officer | 51 | 15-09-23 |
Young-Jin Seo
BRD | Director/Board Member | 44 | - |
Jung-Wook Seo
BRD | Director/Board Member | 62 | 19-06-13 |
Gwang-Min Nam
BRD | Director/Board Member | 44 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 946,591 | 0 | 0 | 66.22 % |
Stock B | 0 | 318,795 | 0 | 0 | |
Stock C | 1 | 15,285,436 | 10,121,649 ( 66.22 %) | 0 |
Company contact information
Genome & Co.
8/F, Pangyo Valley B 35 Pangyo-ro 255beon-gil
13486, Seongnam-si
+
http://www.genomecom.co.kr![address Genome & Company(A314130)](https://cdn.zonebourse.com/static/address/120975398.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-22.82% | 91.92M | |
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |
- Stock Market
- Equities
- A314130 Stock
- Company Genome & Company